Dr. Nandini Verma is a leading cancer biologist and Principal Investigator at the ACTREC – Tata Memorial Centre, with a faculty role at the Homi Bhabha National Institute. Her research focuses on aggressive breast cancers, particularly triple-negative subtypes, exploring cellular plasticity, drug resistance, and targetable vulnerabilities. She has extensive international research experience, including at the Weizmann Institute of Science. With 893 citations, an h-index of 13, and an i10-index of 16, she has established a strong academic impact. She has authored high-impact publications, contributed to patents, and actively mentors graduate and doctoral students while advancing translational cancer research.